Work

Dihydroartemisinic acid dehydrogenase-mediated alternative route for artemisinin biosynthesis

Year: 2025

Type: article

Abstract: Dihydroartemisinic acid (DHAA) converts into antimalarial drug artemisinin (ART) by auto-oxidation. High production of artemisinic acid (AA) has been achieved by fermentation of engineered Saccharomyces cerevisiae, and AA can be converted into ART through DHAA by chemical synthesis. However, there is no enzyme reported to catalyze the conversion of AA to DHAA. Here, we report a dihydroartemisinic acid dehydrogenase (AaDHAADH) from Artemisia annua L, which catalyzes the bidirectional conversion between AA and DHAA. An optimized mutant AaDHAADH (P26L) is obtained through site-directed mutagenesis and its activity toward AA is 2.82 times that of the original gene. De novo synthesis of DHAA is achieved in S. cerevisiae using the targeted optimized gene AaDHAADH (P26L). Furthermore, 3.97 g/L of DHAA is obtained by fermentation of engineered S. cerevisiae in 5 L bioreactor. The discovery of AaDHAADH provides a more convenient and efficient alternative route for ART biosynthesis. Semi-synthesis of artemisinin has been achieved by autooxidation of dihydroartemisinic acid (DHAA), but DHAA supply relies on chemical synthesis from artemisinic acid. Here, authors report the identification of dihydroartemisinic acid dehydrogenase from Artemisia annua and its engineering for DHAA bioproduction in yeast.

Source: Nature Communications

DOI: 10.1038/s41467-025-59312-1